Plant ID: NPO25302
Plant Latin Name: Viola philippica
Taxonomy Genus: Viola
Taxonomy Family: Violaceae
NCBI TaxonomyDB:
316493
Plant-of-the-World-Online:
n.a.
NPSR1; | |
CA13; CA7; CA12; CA9; | |
GFER; HSD17B10; ALDH1A1; ALOX15; | |
CASP7; CASP1; | |
HIF1A; NFKB1; | |
ABCC1; | |
MAPT; | |
XDH; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
ATP-binding cassette | ABCC1 | Multidrug resistance-associated protein 1 | P33527 | CHEMBL3004 |
Cysteine protease | CASP7 | Caspase-7 | P55210 | CHEMBL3468 |
Cysteine protease | CASP1 | Caspase-1 | P29466 | CHEMBL4801 |
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | GFER | FAD-linked sulfhydryl oxidase ALR | P55789 | CHEMBL1741189 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Lyase | CA13 | Carbonic anhydrase XIII | Q8N1Q1 | CHEMBL3912 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Oxidoreductase | XDH | Xanthine dehydrogenase | P47989 | CHEMBL1929 |
Peptide receptor (family A GPCR) | NPSR1 | Neuropeptide S receptor | Q6W5P4 | CHEMBL5162 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 3.019E-11 | 3.287E-07 | CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 2.474E-10 | 1.347E-06 | ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, XDH |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.080E-09 | 3.382E-06 | CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.398E-09 | 3.382E-06 | CA12, CA13, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 2.210E-08 | 3.008E-05 | CYP1A2, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 5.944E-08 | 6.472E-05 | CA12, CA13, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 1.322E-07 | 1.186E-04 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.362E-07 | 1.186E-04 | CA12, CA13, CA7, CA9 |
MF | GO:0005488; binding | GO:0020037; heme binding | 2.208E-07 | 1.849E-04 | CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 2.421E-07 | 1.941E-04 | CYP1A2, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0017144; drug metabolic process | 9.135E-07 | 5.850E-04 | ABCC1, ALDH1A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 1.454E-06 | 8.798E-04 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0065007; biological regulation | GO:0006919; activation of cysteine-type endopeptidase activity involved in apoptotic process | 1.709E-06 | 1.006E-03 | CASP1, CASP7, MAPT, XDH |
BP | GO:0008152; metabolic process | GO:0009404; toxin metabolic process | 1.934E-06 | 1.080E-03 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 3.375E-06 | 1.709E-03 | CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0070576; vitamin D 24-hydroxylase activity | 3.375E-06 | 1.709E-03 | CYP1A1, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0018894; dibenzo-p-dioxin metabolic process | 6.746E-06 | 2.825E-03 | CYP1A1, CYP1A2 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 6.746E-06 | 2.825E-03 | CYP1A2, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0014070; response to organic cyclic compound | 7.616E-06 | 3.129E-03 | CA9, CASP1, CASP7, CYP1A1, CYP1A2, CYP1B1, NFKB1 |
MF | GO:0003824; catalytic activity | GO:0101020; estrogen 16-alpha-hydroxylase activity | 1.124E-05 | 4.292E-03 | CYP1A1, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0002933; lipid hydroxylation | 1.684E-05 | 6.112E-03 | CYP1A1, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009804; coumarin metabolic process | 2.356E-05 | 7.894E-03 | CYP1A1, CYP2D6 |
BP | GO:0008152; metabolic process | GO:2000377; regulation of reactive oxygen species metabolic process | 3.013E-05 | 9.941E-03 | CYP1B1, HIF1A, MAPT, XDH |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.096E-08 | 4.383E-07 | CYP2D6, CYP1A2, CYP1A1, CYP1B1, CYP3A4 |
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 2.118E-09 | 1.695E-07 | CA12, CA7, CA9, CA13 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 3.673E-07 | 9.793E-06 | CYP1A2, CYP1A1, CYP1B1, CYP3A4 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 5.833E-07 | 1.167E-05 | CYP1A2, ALDH1A1, CYP1A1, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.489E-06 | 2.383E-05 | CYP1A2, CYP1A1, CYP1B1, CYP3A4 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 9.614E-06 | 1.048E-04 | CYP1A2, CYP1A1, CYP1B1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 3.582E-06 | 4.776E-05 | CYP1A2, ALOX15, CYP3A4 |
09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 2.527E-05 | 2.246E-04 | CASP7, CASP1, NFKB1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 4.999E-05 | 3.999E-04 | CYP2D6, CYP1A2, CYP3A4 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.853E-04 | 1.235E-03 | CYP1A2, ALOX15, ALDH1A1, CYP1A1, CYP3A4, HSD17B10, XDH |
09160 Human Diseases | 09167 Infectious diseases | hsa05133 | Pertussis | 6.417E-05 | 4.667E-04 | CASP7, CASP1, NFKB1 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05010 | Alzheimer's disease | 6.928E-04 | 4.263E-03 | CASP7, MAPT, HSD17B10 |
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 1.248E-03 | 6.655E-03 | CYP1A1, CYP1B1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 1.057E-03 | 6.040E-03 | CYP3A4, XDH |
09150 Organismal Systems | 09151 Immune system | hsa04621 | NOD-like receptor signaling pathway | 1.619E-03 | 8.093E-03 | CASP1, NFKB1 |
09150 Organismal Systems | 09151 Immune system | hsa04623 | Cytosolic DNA-sensing pathway | 2.035E-03 | 9.579E-03 | CASP1, NFKB1 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 1.048E-05 | 1.048E-04 | CYP1A2, XDH |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9; |
C00-D49: Neoplasms | Cancer | C00-C96 | CA9; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9; |
C00-D49: Neoplasms | Renal cancer | C64 | CA9; |
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | MAPT; |
C00-D49: Neoplasms | Breast cancer | C50 | CA9; |
G00-G99: Diseases of the nervous system G00-G99 | Central nervous system disease | G00-G99 | MAPT; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | MAPT; |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | MAPT; |